Takeda’s seriousness towards Trial Representation to revolutionise the Clinical Research sector

Announcement

Takeda, with a strong footprint in Europe, Japan, and the US, and popularly recognised for its Entyvio for IBD, as Asia’s third-largest pharmaceutical company, shed some light on the trial representation. Takeda raises awareness and value for its patients regarding the company’s clinical trials. Takeda's internal initiatives and meetings are always valuable either to the business or the patients; it works best for the future of the healthcare sector.

From Takeda’s research and development department, two of the employees had a discussion round on the questions regarding the importance of representation and how their team is working to introduce the best of the Trial representations that will benefit the patients.

Story behind the Discussion

The director of trial equity and representation, Takeda, Angel Akinbinu feels that the clinical trial representation is a familiar issue, which she recalls saying that she and her sister had the same rare diseases. While going through these diseases, the medical professionals didn’t inform or explain about the clinical research for the same. We never knew this was also an option. Likewise, there was again a similar experience when her father was diagnosed with late-stage pancreatic cancer.

This time, she herself looked closely at the issue and was thoroughly looking for clinical trials, but the time passed, and so did her father. This personal loss and disappointment made Akinbinu think about this issue professionally to help the patients. She is now a leader of Takeda’s trial equity initiative space. Along with her team members and their roles to bring partnership to the table and introduce new smart strategies aiming at education, awareness and reach became the main mission of Takeda’s journey.

Akinbinu and her team gather the group suffering from several diseases with no specific segregation of factors like gender, ethnicity, race, age and social position. Further, they give details of clinical trials via different ways that centralise awareness, education and access.

This social cum awareness initiative bolsters the mission, vision and values of the company and builds a healthier future for many individuals. Further, it promotes the values like honesty, kindness, perseverance, fairness and integrity. The creative, messaging and branding face for clinical trial retention and recruitment, Butko said, “Mostly it’s a business juggling which is essential, but I’m happy for the fact that the company make sure the projects which we approach are running best and well aligned with the values.”